entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 15:31:53 - browse：362

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

Wikipedia

entertainment

WSS

What affirmative action's end means to a medical student

AstraZeneca lung cancer study comes in below expectations

Congenital heart disease patients face new threat of heart failure

STAT letters to the editor on burnt

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Security flaws in third

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

In Memoriam: Notable people who died in 2023

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA approves world's first CRISPR

Tori Bowie and the unacceptable rates of Black maternal death

STAT letters to the editor on burnt

Virginia high school admissions case could be legal follow

The biotech scorecard for Q3: 15 stock

Cancer drug shortages should be causing more outrage

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

focus

Supreme Court wrestles with OxyContin maker's bankruptcy deal

CMS should re

Drug cartel violence flares in western Mexico after vigilante leader's killing

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Hubble vs. James Webb telescope images: See the difference

explore

Wikipedia

entertainment

explore